Glaxo, Watson Strike $35M Deal Over Wellbutrin
Law360 (February 12, 2007, 12:00 AM EST) -- Watson Pharmaceuticals Inc. and GlaxoSmithKline have struck a deal that will resolve a patent suit brought in 2005 over the extended release version of the blockbuster depression treatment Wellbutrin XL....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
